Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
Magenta Therapeutics Inc (MGTA)
NASDAQ:MGTA
Magenta Therapeutics (MGTA) Stock Price & Analysis
248 Followers
MGTA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.32 - $2.24
Previous Close$0.68
Volume1.85K
Average Volume (3M)502.75K
Market Cap
$42.45M
Enterprise Value-$38.74M
Total Cash (Recent Filing)$79.99M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.5
Beta1.76
Next Earnings
Aug 10, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.38
Shares Outstanding60,648,883
10 Day Avg. Volume368,784
30 Day Avg. Volume502,751
Standard Deviation0.24
R-Squared0.22
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.44
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
Magenta Therapeutics News
Pre-EarningsMGTA Earnings this Week: How Will it Perform?
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MGTA FAQ
What was Magenta Therapeutics Inc’s price range in the past 12 months?
Magenta Therapeutics Inc lowest stock price was $0.32 and its highest was $2.24 in the past 12 months.
What is Magenta Therapeutics Inc’s market cap?
Currently, no data Available
When is Magenta Therapeutics Inc’s upcoming earnings report date?
Magenta Therapeutics Inc’s upcoming earnings report date is Aug 10, 2023 which is in 69 days.
How were Magenta Therapeutics Inc’s earnings last quarter?
Magenta Therapeutics Inc released its earnings results on May 11, 2023. The company reported -$0.47 earnings per share for the quarter, the consensus estimate of -$0.47 by $0.
Is Magenta Therapeutics Inc overvalued?
According to Wall Street analysts Magenta Therapeutics Inc’s price is currently Overvalued.
Does Magenta Therapeutics Inc pay dividends?
Magenta Therapeutics Inc does not currently pay dividends.
What is Magenta Therapeutics Inc’s EPS estimate?
Magenta Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Magenta Therapeutics Inc have?
Magenta Therapeutics Inc has 60,648,884 shares outstanding.
What happened to Magenta Therapeutics Inc’s price movement after its last earnings report?
Magenta Therapeutics Inc reported an EPS of -$0.47 in its last earnings report, expectations of -$0.47. Following the earnings report the stock price went down -4.225%.
Which hedge fund is a major shareholder of Magenta Therapeutics Inc?
Among the largest hedge funds holding Magenta Therapeutics Inc’s share is Western Standard Llc. It holds Magenta Therapeutics Inc’s shares valued at 1M.
---
Magenta Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Hedge Fund Trend
Increased
By 1.4M Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Negative
20 days / 200 days
Momentum
-38.73%
12-Months-Change
Fundamentals
Return on Equity
-72.32%
Trailing 12-Months
Asset Growth
-57.07%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Magenta Therapeutics Inc
Magenta Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of novel medicines for bone marrow transplants. It offers platform that focuses on critical areas of transplant medicine. The company was founded by David Scadden, Derrick Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner in June 2015 and is headquartered in Cambridge, MA.
---
Top 5 ETFs holding MGTA
iShares Core S&P Total U.S. Stock Market ETF
$12.61K
Up to five ETFs with an Outperform Smart Score that hold MGTA. The ETFs are listed according to market value of MGTA within the ETF
---
---